Oral mucositisis a painful and debilitating side-effect of many cancer treatments
40% of chemotherapy patients and 70% of patients receiving head and neck cancer therapies develop oral mucositis, resulting in pain, complications with speech and even inability to eat.
Oncolum is a revolutionary photobiomodulation device designed for the prevention and treatment of oral mucositis.
When used for just 2 minutes 4-5 times per week, Oncolum can effectively manage oral mucositis through a self-administered therapy that fits seamlessly into any patient’s everyday routine. Whether used in-office or at home, Oncolum offers unparalleled care and convenience.
Oncolum helps to up keep normal oral functions during cancer treatment
Oncolum uses red (660nm) and near-infrared (810nm) LED light to energize cells, boosting ATP production and enhancing cell vitality. By improving blood flow, reducing swelling and stimulating a stronger immune response, Oncolum targets oral mucositis at its core.
✓ Increased ATP production
✓ Improved cellular health*
✓ Greater blood flow
✓ Reduced swelling
✓Enhanced immune response
RED and NIR (near-Infrared) Photobiomodulation stimulates mitochondria to boost ATP (cellular energy) while also promoting nitric oxide (NO) release, enhancing blood flow and oxygen delivery, and reducing oxidative stress. The process also reduces inflammation by influencing cytokine levels in certain contexts.
Photobiomodulation reduces
the severity & duration of oral mucositis.
RED and NIR (near-Infrared) Photobiomodulation stimulates mitochondria to boost ATP (cellular energy) while also promoting nitric oxide (NO) release, enhancing blood flow and oxygen delivery, and reducing oxidative stress. The process also reduces inflammation by influencing cytokine levels in certain contexts.
Photobiomodulation reduces
the severity & duration of oral mucositis.
Why Oncolum?
Only Oncolum offers clinical-grade treatment paired with portability and flexibility to support greater frequency and longer durations not supported through in-office alone.
For more information contact: info@koitehealth.com
The Oncolum device is currently under development and is not available for sale. It has not been evaluated by the U.S. Food and Drug Administration (FDA) and is not intended to diagnose, treat, cure, or prevent any disease. All content is provided for informational and research purposes only.